TY - JOUR
T1 - Extraocular muscle ductions following nasal transposition of the split lateral rectus muscle
AU - NTSLR3NP Study Group
AU - Oke, Isdin
AU - Lorenz, Birgit
AU - Basiakos, Sotirios
AU - Gokyigit, Birsen
AU - Dodd, Mary Magdalene Ugo
AU - Laurent, Erick
AU - Sadiq, Mohammad Ali
AU - Goberville, Mitra
AU - Elkamshoushy, Amr
AU - Tsai, Chong bin
AU - Gravier, Nicholas
AU - Speeg-Schatz, Claude
AU - Shepherd, James Banks
AU - Saxena, Rohit
AU - Soni, Ajay
AU - Hunter, David G.
AU - Shah, Ankoor S.
AU - Dagi, Linda R.
N1 - Publisher Copyright:
© 2022 Canadian Ophthalmological Society
PY - 2023/12
Y1 - 2023/12
N2 - Objective: To quantify changes in ductions following nasal transposition of the split lateral rectus muscle (NTSLR) for treating third nerve palsy. Design: Retrospective cohort study. Participants: A single eye from each patient with third nerve palsy treated with NTSLR with ocular motility measurements. Methods: Observation of changes in pre- and postoperative ductions. Outcome measures including patient demographic and surgical factors associated with the ability to adduct beyond the midline after NTSLR were evaluated using multivariable logistic regression. Results: A total of 116 patients met the inclusion criteria for this study. The NTSLR significantly decreased abduction (median of 0 limitation [interquartile range (IQR), 0–0] prior to surgery to –4 [IQR, –4 to –3] after NTSLR; p < 0.001), with a corresponding improvement in adduction (median, –5 [IQR, –5 to –4] prior to surgery to –4 [IQR, –4 to –3] after NTSLR; p < 0.001). There was no change in median supraduction or infraduction after NTSLR (p > 0.05). The ability to adduct beyond the midline after NTSLR was demonstrated in 42% of patients. Although not statistically significant, a trend toward a postoperative ability to adduct beyond the midline was seen in patients who had concurrent superior oblique muscle tenotomy (odds ratio [OR] = 5.08; 95% CI, 0.91–40.9) or who were designated with partial rather than complete third nerve palsy (OR = 2.29; 95% CI, 0.82–6.70). Conclusions: NTSLR improves the horizontal midline positioning of eyes with third nerve palsy. Most eyes lose the ability to abduct, but some regain a modest ability to adduct while vertical ductions remain unchanged.
AB - Objective: To quantify changes in ductions following nasal transposition of the split lateral rectus muscle (NTSLR) for treating third nerve palsy. Design: Retrospective cohort study. Participants: A single eye from each patient with third nerve palsy treated with NTSLR with ocular motility measurements. Methods: Observation of changes in pre- and postoperative ductions. Outcome measures including patient demographic and surgical factors associated with the ability to adduct beyond the midline after NTSLR were evaluated using multivariable logistic regression. Results: A total of 116 patients met the inclusion criteria for this study. The NTSLR significantly decreased abduction (median of 0 limitation [interquartile range (IQR), 0–0] prior to surgery to –4 [IQR, –4 to –3] after NTSLR; p < 0.001), with a corresponding improvement in adduction (median, –5 [IQR, –5 to –4] prior to surgery to –4 [IQR, –4 to –3] after NTSLR; p < 0.001). There was no change in median supraduction or infraduction after NTSLR (p > 0.05). The ability to adduct beyond the midline after NTSLR was demonstrated in 42% of patients. Although not statistically significant, a trend toward a postoperative ability to adduct beyond the midline was seen in patients who had concurrent superior oblique muscle tenotomy (odds ratio [OR] = 5.08; 95% CI, 0.91–40.9) or who were designated with partial rather than complete third nerve palsy (OR = 2.29; 95% CI, 0.82–6.70). Conclusions: NTSLR improves the horizontal midline positioning of eyes with third nerve palsy. Most eyes lose the ability to abduct, but some regain a modest ability to adduct while vertical ductions remain unchanged.
UR - http://www.scopus.com/inward/record.url?scp=85143690608&partnerID=8YFLogxK
U2 - 10.1016/j.jcjo.2022.10.019
DO - 10.1016/j.jcjo.2022.10.019
M3 - Article
C2 - 36372135
AN - SCOPUS:85143690608
SN - 0008-4182
VL - 58
SP - 565
EP - 569
JO - Canadian Journal of Ophthalmology
JF - Canadian Journal of Ophthalmology
IS - 6
ER -